Summary: 4.5 months. Safety information is provided for 429 patients from three controlled clinical studies and one open label study (Table 3). The adverse events are reported regardless of causality. The most common adverse events reported by patients receiving 5-30 mg/ day DITROPAN XL were the expected side effects of anticholinergic agents. The incidence of dry mouth was dose-related.
Image Dimensions: 367 x 276
Image originally found here.